0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Typhoid Fever Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-23J780
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Typhoid Fever Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Typhoid Fever Vaccines Market Research Report 2025

Code: QYRE-Auto-23J780
Report
September 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Typhoid Fever Vaccines Market Size

The global market for Typhoid Fever Vaccines was valued at US$ 244 million in the year 2024 and is projected to reach a revised size of US$ 346 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Typhoid Fever Vaccines Market

Typhoid Fever Vaccines Market

Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Typhoid Fever Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Fever Vaccines.
The Typhoid Fever Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Typhoid Fever Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Typhoid Fever Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Typhoid Fever Vaccines Market Report

Report Metric Details
Report Name Typhoid Fever Vaccines Market
Accounted market size in year US$ 244 million
Forecasted market size in 2031 US$ 346 million
CAGR 5.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Live Attenuated Vaccine
  • Conjugate Vaccine
  • Capsular Polysaccharide Vaccines
  • Others
Segment by Application
  • Government Institution
  • Private Sector
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium, China National Biotec Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Typhoid Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Typhoid Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Typhoid Fever Vaccines Market growing?

Ans: The Typhoid Fever Vaccines Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Typhoid Fever Vaccines Market size in 2031?

Ans: The Typhoid Fever Vaccines Market size in 2031 will be US$ 346 million.

Who are the main players in the Typhoid Fever Vaccines Market report?

Ans: The main players in the Typhoid Fever Vaccines Market are Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium, China National Biotec Group

What are the Application segmentation covered in the Typhoid Fever Vaccines Market report?

Ans: The Applications covered in the Typhoid Fever Vaccines Market report are Government Institution, Private Sector

What are the Type segmentation covered in the Typhoid Fever Vaccines Market report?

Ans: The Types covered in the Typhoid Fever Vaccines Market report are Live Attenuated Vaccine, Conjugate Vaccine, Capsular Polysaccharide Vaccines, Others

1 Typhoid Fever Vaccines Market Overview
1.1 Product Definition
1.2 Typhoid Fever Vaccines by Type
1.2.1 Global Typhoid Fever Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Attenuated Vaccine
1.2.3 Conjugate Vaccine
1.2.4 Capsular Polysaccharide Vaccines
1.2.5 Others
1.3 Typhoid Fever Vaccines by Application
1.3.1 Global Typhoid Fever Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Government Institution
1.3.3 Private Sector
1.4 Global Typhoid Fever Vaccines Market Size Estimates and Forecasts
1.4.1 Global Typhoid Fever Vaccines Revenue 2020-2031
1.4.2 Global Typhoid Fever Vaccines Sales 2020-2031
1.4.3 Global Typhoid Fever Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Typhoid Fever Vaccines Market Competition by Manufacturers
2.1 Global Typhoid Fever Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Typhoid Fever Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Typhoid Fever Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Typhoid Fever Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Typhoid Fever Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Typhoid Fever Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Typhoid Fever Vaccines, Date of Enter into This Industry
2.8 Global Typhoid Fever Vaccines Market Competitive Situation and Trends
2.8.1 Global Typhoid Fever Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Typhoid Fever Vaccines Players Market Share by Revenue
2.8.3 Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Typhoid Fever Vaccines Market Scenario by Region
3.1 Global Typhoid Fever Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Typhoid Fever Vaccines Sales by Region: 2020-2031
3.2.1 Global Typhoid Fever Vaccines Sales by Region: 2020-2025
3.2.2 Global Typhoid Fever Vaccines Sales by Region: 2026-2031
3.3 Global Typhoid Fever Vaccines Revenue by Region: 2020-2031
3.3.1 Global Typhoid Fever Vaccines Revenue by Region: 2020-2025
3.3.2 Global Typhoid Fever Vaccines Revenue by Region: 2026-2031
3.4 North America Typhoid Fever Vaccines Market Facts & Figures by Country
3.4.1 North America Typhoid Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Typhoid Fever Vaccines Sales by Country (2020-2031)
3.4.3 North America Typhoid Fever Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Typhoid Fever Vaccines Market Facts & Figures by Country
3.5.1 Europe Typhoid Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Typhoid Fever Vaccines Sales by Country (2020-2031)
3.5.3 Europe Typhoid Fever Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Typhoid Fever Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Typhoid Fever Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Typhoid Fever Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Typhoid Fever Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Typhoid Fever Vaccines Market Facts & Figures by Country
3.7.1 Latin America Typhoid Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Typhoid Fever Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Typhoid Fever Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Typhoid Fever Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Typhoid Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Typhoid Fever Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Typhoid Fever Vaccines Sales by Type (2020-2031)
4.1.1 Global Typhoid Fever Vaccines Sales by Type (2020-2025)
4.1.2 Global Typhoid Fever Vaccines Sales by Type (2026-2031)
4.1.3 Global Typhoid Fever Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Typhoid Fever Vaccines Revenue by Type (2020-2031)
4.2.1 Global Typhoid Fever Vaccines Revenue by Type (2020-2025)
4.2.2 Global Typhoid Fever Vaccines Revenue by Type (2026-2031)
4.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Typhoid Fever Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Typhoid Fever Vaccines Sales by Application (2020-2031)
5.1.1 Global Typhoid Fever Vaccines Sales by Application (2020-2025)
5.1.2 Global Typhoid Fever Vaccines Sales by Application (2026-2031)
5.1.3 Global Typhoid Fever Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Typhoid Fever Vaccines Revenue by Application (2020-2031)
5.2.1 Global Typhoid Fever Vaccines Revenue by Application (2020-2025)
5.2.2 Global Typhoid Fever Vaccines Revenue by Application (2026-2031)
5.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Typhoid Fever Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Typhoid Fever Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Typhoid Fever Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Bharat Biotech
6.3.1 Bharat Biotech Company Information
6.3.2 Bharat Biotech Description and Business Overview
6.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bharat Biotech Typhoid Fever Vaccines Product Portfolio
6.3.5 Bharat Biotech Recent Developments/Updates
6.4 PaxVax
6.4.1 PaxVax Company Information
6.4.2 PaxVax Description and Business Overview
6.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 PaxVax Typhoid Fever Vaccines Product Portfolio
6.4.5 PaxVax Recent Developments/Updates
6.5 Biomed
6.5.1 Biomed Company Information
6.5.2 Biomed Description and Business Overview
6.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biomed Typhoid Fever Vaccines Product Portfolio
6.5.5 Biomed Recent Developments/Updates
6.6 Prokarium
6.6.1 Prokarium Company Information
6.6.2 Prokarium Description and Business Overview
6.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Prokarium Typhoid Fever Vaccines Product Portfolio
6.6.5 Prokarium Recent Developments/Updates
6.7 China National Biotec Group
6.7.1 China National Biotec Group Company Information
6.7.2 China National Biotec Group Description and Business Overview
6.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China National Biotec Group Typhoid Fever Vaccines Product Portfolio
6.7.5 China National Biotec Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Typhoid Fever Vaccines Industry Chain Analysis
7.2 Typhoid Fever Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Typhoid Fever Vaccines Production Mode & Process Analysis
7.4 Typhoid Fever Vaccines Sales and Marketing
7.4.1 Typhoid Fever Vaccines Sales Channels
7.4.2 Typhoid Fever Vaccines Distributors
7.5 Typhoid Fever Vaccines Customer Analysis
8 Typhoid Fever Vaccines Market Dynamics
8.1 Typhoid Fever Vaccines Industry Trends
8.2 Typhoid Fever Vaccines Market Drivers
8.3 Typhoid Fever Vaccines Market Challenges
8.4 Typhoid Fever Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Typhoid Fever Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Typhoid Fever Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Typhoid Fever Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Typhoid Fever Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Typhoid Fever Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Typhoid Fever Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Typhoid Fever Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Typhoid Fever Vaccines Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Typhoid Fever Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Typhoid Fever Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Typhoid Fever Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Typhoid Fever Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Typhoid Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Fever Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Typhoid Fever Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Typhoid Fever Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Typhoid Fever Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Typhoid Fever Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Typhoid Fever Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Typhoid Fever Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Typhoid Fever Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Typhoid Fever Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Typhoid Fever Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Typhoid Fever Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Typhoid Fever Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Typhoid Fever Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Typhoid Fever Vaccines Sales (K Doses) by Type (2020-2025)
 Table 51. Global Typhoid Fever Vaccines Sales (K Doses) by Type (2026-2031)
 Table 52. Global Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Typhoid Fever Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Typhoid Fever Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Typhoid Fever Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Typhoid Fever Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Typhoid Fever Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Typhoid Fever Vaccines Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Typhoid Fever Vaccines Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Typhoid Fever Vaccines Sales (K Doses) by Application (2020-2025)
 Table 61. Global Typhoid Fever Vaccines Sales (K Doses) by Application (2026-2031)
 Table 62. Global Typhoid Fever Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Typhoid Fever Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Typhoid Fever Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Typhoid Fever Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Typhoid Fever Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Typhoid Fever Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Typhoid Fever Vaccines Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Typhoid Fever Vaccines Price (USD/Dose) by Application (2026-2031)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur Typhoid Fever Vaccines Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Typhoid Fever Vaccines Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Bharat Biotech Company Information
 Table 81. Bharat Biotech Description and Business Overview
 Table 82. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Bharat Biotech Typhoid Fever Vaccines Product
 Table 84. Bharat Biotech Recent Developments/Updates
 Table 85. PaxVax Company Information
 Table 86. PaxVax Description and Business Overview
 Table 87. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. PaxVax Typhoid Fever Vaccines Product
 Table 89. PaxVax Recent Developments/Updates
 Table 90. Biomed Company Information
 Table 91. Biomed Description and Business Overview
 Table 92. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Biomed Typhoid Fever Vaccines Product
 Table 94. Biomed Recent Developments/Updates
 Table 95. Prokarium Company Information
 Table 96. Prokarium Description and Business Overview
 Table 97. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Prokarium Typhoid Fever Vaccines Product
 Table 99. Prokarium Recent Developments/Updates
 Table 100. China National Biotec Group Company Information
 Table 101. China National Biotec Group Description and Business Overview
 Table 102. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. China National Biotec Group Typhoid Fever Vaccines Product
 Table 104. China National Biotec Group Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Typhoid Fever Vaccines Distributors List
 Table 108. Typhoid Fever Vaccines Customers List
 Table 109. Typhoid Fever Vaccines Market Trends
 Table 110. Typhoid Fever Vaccines Market Drivers
 Table 111. Typhoid Fever Vaccines Market Challenges
 Table 112. Typhoid Fever Vaccines Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Typhoid Fever Vaccines
 Figure 2. Global Typhoid Fever Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Typhoid Fever Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Live Attenuated Vaccine Product Picture
 Figure 5. Conjugate Vaccine Product Picture
 Figure 6. Capsular Polysaccharide Vaccines Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Typhoid Fever Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Typhoid Fever Vaccines Market Share by Application: 2024 & 2031
 Figure 10. Government Institution
 Figure 11. Private Sector
 Figure 12. Global Typhoid Fever Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Typhoid Fever Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Typhoid Fever Vaccines Sales (2020-2031) & (K Doses)
 Figure 15. Global Typhoid Fever Vaccines Average Price (USD/Dose) & (2020-2031)
 Figure 16. Typhoid Fever Vaccines Report Years Considered
 Figure 17. Typhoid Fever Vaccines Sales Share by Manufacturers in 2024
 Figure 18. Global Typhoid Fever Vaccines Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Typhoid Fever Vaccines Players: Market Share by Revenue in Typhoid Fever Vaccines in 2024
 Figure 20. Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Typhoid Fever Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
 Figure 23. North America Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
 Figure 27. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Typhoid Fever Vaccines Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Typhoid Fever Vaccines Revenue Market Share by Region (2020-2031)
 Figure 35. China Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Typhoid Fever Vaccines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Typhoid Fever Vaccines by Type (2020-2031)
 Figure 57. Global Typhoid Fever Vaccines Price (USD/Dose) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Typhoid Fever Vaccines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Typhoid Fever Vaccines by Application (2020-2031)
 Figure 60. Global Typhoid Fever Vaccines Price (USD/Dose) by Application (2020-2031)
 Figure 61. Typhoid Fever Vaccines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture